Interim / Quarterly Report • Sep 23, 2015
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
ADDRESS OF HEAD OFFICES: ERMOU 2, ATHENS
DATA AND INFORMATION FOR THE PERIOD FROM 1st JANUARY 2009 TO 30th JUNE 2009 In accordance with the Decision 4/507/28.04.2009 of the Capital Market Committee Board of Directors.
The following condensed financial statements, data and information deriving from the interim financial statements, aim to provide a general briefing for the financial position and the results of the Group and the Parent Co the review report of the certified auditor accountant (whenever required) are posted.
| COMPANY INFORMATION | Board of Directors: | Terzopoulos Apostolos, Chairman | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company's website address: | www.axonholdings.gr | Doumanoglou Panagiotis, Managing Director | |||||||||||
| Date of approval of the financial statements by the Board of Directors. |
August 26 2009 | Nanopoulos Dimitrios, non executive member Nikolaidis Petros, non executive member |
|||||||||||
| Certified Auditor: | Vrasidas Sp. Damilakos SOEL R.N. 22791 BDO PROTYPOS HELLENIC AUDITING Co SOEL R.N. 111 |
Paka Paraskeui, non executive member | |||||||||||
| Audit Company: Type of Review Report: |
Unqualified Opinion - Emphasis matter | ||||||||||||
| STATEMENT OF FINANCIAL POSITION (consolidated and not consolidated) Amounts in thousands of Euro |
STATEMENT OF COMPREHENSIVE INCOME (consolidated and not consolidated) Amounts in thousands of Euro |
||||||||||||
| COMPANY GROUP |
GROUP | COMPANY | |||||||||||
| ASSETS Tangible assets for own use |
30/06/2009 393.504 |
31/12/2008 370.051 |
30/06/2009 4.379 |
31/12/2008 4.588 |
Sales | 1/1-30/6/09 134.770 |
1/1-30/6/08 129.380 |
1/4-30/6/09 68.653 |
1/4-30/6/08 69.689 |
1/1-30/6/09 1.920 |
1/1-30/6/08 2.985 |
1/4-30/6/09 1.152 |
1/4-30/6/08 1.367 |
| Investment property | 30.638 | 30.628 | 34.881 | 34.871 | Gross profit / [loss] Profit / (loss) before taxes, financing |
29.678 | 25.314 | 14.380 | 14.215 | 261 | [49] | 553 | 58 |
| Intangible assets Other non-current assets |
136.253 68.714 |
135.579 72.503 |
990 114.103 |
1.421 114.927 |
and investing results | 16.954 | 10.979 | 7.832 | 5.860 | 77 | [214] | 59 | 32 |
| Inventories | 25.197 | 27.064 109.825 |
328 | 1.162 1.789 |
E.B.I.T.D.A. Profit / (loss) before taxes |
25.219 7.962 |
18.841 (15.013) |
12.407 4.551 |
10.278 (3.066) |
717 [944] |
1.227 (269) |
381 (303) |
1.293 425 |
| Trade and other receivables Other long term assets |
122.570 137.356 |
124.438 | 1.274 224 |
247 | Profit / [loss] after taxes [A] | 5.828 | (15.442) | 3.727 | (5.487) | (905) | $\overline{z}$ | (312) | 595 |
| Available for sale non-current assets TOTAL ASSETS |
O | $\Omega$ | n | D | - Owners of the parent Minority interests |
2.332 3.496 |
(10.034) (5.408) |
1.820 1.907 |
(4.030) (1.457) |
(905) 0 |
2 | [312] O. |
595 O |
| EQUITY AND LIABILITIES | 914.232 | 870.088 | 156.179 | 159.005 | Other comprehensive income after taxes (B) | 1.636 | a | 3.249 | $\theta$ | 44 | ٥ | 44 | 0 |
| Share capital | 24.712 | 24.712 | 24.712 | 24.712 | Total comprehensive income after taxes (A) + (B) |
7.464 | (15.442) | 6.976 | (5.487) | (861) | 2 | [268] | 595 |
| Other Shareholders' Equity items Total Equity attributable to parent's shareholders (a) |
87.398 112.110 |
84.007 108.719 |
73.612 98.324 |
74.472 99.184 |
Owners of the parent Minority interests |
3.372 4.092 |
(10.034) (5.408) |
3.850 3.126 |
(4.030) (1.457) |
[846] $\Omega$ |
2 ō |
[253] o |
595 $\mathbf{0}$ |
| Minority Interests (b) | 118.945 | 117.749 | 0 | 0 | Earnings / (loss) per share after | ||||||||
| Total Equity $[c] = [a] + [b]$ Long term bank borrowings |
231.055 325.083 |
226.468 301.473 |
98.324 38.738 |
99.184 35.969 |
taxes - basic (in €) Earnings / (loss) before taxes, financing |
0,0610 | [0,2621] | 0,0476 | (0.1053) | (0.0224) | 0,0001 | (0.0077) | 0.0148 |
| Provisions and other long term liabilities | 41.189 | 42.475 | 7.400 | 7.956 | and investing results and total depreciation 25.196 | 18.902 | 12.421 | 10.215 | 717 | 960 | 381 | 1.026 | |
| Short term bank borrowings Other short term liabilities |
104.785 212.120 |
108,680 190.992 |
7.782 3.935 |
10.595 5.301 |
CASH FLOW STATEMENT | ||||||||
| Liabilities associated with available for sale non-current assets | n | n | O | [consolidated and not consolidated] Amounts in thousands of Euro | |||||||||
| Total liabilities (d) TOTAL EQUITY AND LIABILITIES (c) + (d) |
683.177 914.232 |
643.620 870.088 |
57.855 156.179 |
59.821 159.005 |
GROUP 1/1-30/06/2009 1/1-30/06/2008 1/1-30/06/2009 1/1-30/06/2008 |
COMPANY | |||||||
| Cash flows from operating activities; | |||||||||||||
| STATEMENTS OF CHANGES IN EQUITY | Earnings / [losses] before taxes Plus (less) adjustments for: |
7.962 | (15.013) | (944) | [269] | ||||||||
| (consolidated and not consolidated) Amounts in thousands of Euro | GROUP | COMPANY | Depreciation and amortisation expenses | 8.309 773 |
7.961 2.763 |
640 | 25 | 1.174 42 |
|||||
| 30/06/2009 | 30/06/2008 | 30/06/2009 | 30/06/2008 | Provisions Loss / (gain) from disposal of fixed assets |
44 | 98 | 0 | [267] | |||||
| Total equity at the begining of the period (01/01/2009 and 01/01/2008 respectively) |
226,468 | 258.588 | 99.184 | 103.402 | Loss / (gain) from investments sales Amortisation of government grants |
2.338 (66) |
17.919 (37) |
0 o |
[294] O |
||||
| Total comprehensive income after taxes | 7.464 | (15.442) | [860] | Income from participations | (1.269) | [2.190] | 0 | (1.008) | |||||
| Increase / [Decrease] in share capital Expenses of increase in share capital |
o n |
(4.051) (620) |
o $\Omega$ |
[4.051] (620) |
Loss / (gain) from participations in associates Debit interest and other related expenses |
(263) 8.142 |
(343) 10.137 |
1.021 | o | $\Omega$ 1.623 |
|||
| Dividends | (1.535) | (637) | o | o | Plus / (less) adjustements for changes in working capital | 25.971 | 21.295 | 742 | 1,001 | ||||
| and consolidation of new subsidiaries | Change in existing subsidiaries' participating interests [1.342] (7.082) o O |
||||||||||||
| [Purchases] / Sales of treasury shares Total equity at the end of the period |
0 | (86) | $\Omega$ | (74) | or operating activities accounts. [Increase] / decrease in inventories |
1.867 | 4.540 | 834 | (367) | ||||
| (30/06/2009 and 30/06/2008 respectively) | 231.055 | 230.670 | 98.324 | 98.659 | [Increase] / decrease in trade and other receivalbes Increase / (decrease) in payables (less loans) |
[29.750] 22.995 |
(6.866) (37.980) |
489 1.608 |
1.862 (11.003) |
||||
| [Less]. | |||||||||||||
| ADDITIONAL DATA AND INFORMATION | Debit interest and other related expenses paid Income taxes paid |
(7.846) (4.915) |
(10.049) [7.796] |
(1.021) (200) |
[1.642] [1.320] |
||||||||
| . The emphasis matter in the Certified Auditor's Report refers to unresolved claims pending and courts' decisions pending. 2. The names of all companies (separate and consolidated) included in the condensed financial statements, their country, th |
Net cash (used in) / generated from operating activities (a) | 8.322 | [36.854] | 2.452 | [11.469] | ||||||||
| Group's participating interest as well as the consolidation method, are presented in Note 3 of the interim financial statements. 3. Note 25.4 of the interim financial statements refers to the tax unaudited fiscal years of the companies included in the |
Cash flows from investing activities: Acquisitions of subsidiaries, affiliates, joint ventures and other investments [10.159] |
(33.657) | (61) | [11.036] | |||||||||
| consolidated financial statements. | Purchase of treasury shares | (85) | (73) | ||||||||||
| 4. The Group and the Company are involved in a number of legal proceedings and have various unresolved claims pending (Group: € 47.032 k., Company € 0 k. ], most of whom are covered by special insurance contracts and it is estimated that their outcome will not |
Purchase of tangible & intangible assets Proceeds from tangible and intagibles assets sales |
(30.750) 71 |
[23.845] 471 |
0 | [334] 14.403 |
||||||||
| have a material effect on the operating results and financial position of the Group and the Company. 5. The Group and the Company have not formed provisions for unresolved or under arbitration legally prosecuted claims or courts |
Proceeds from financial assets and investments sales | 10.271 | 19.748 | 943 | 1.898 | ||||||||
| decisions nor arbitration awards, as the outcome of such pending cases is estimated not to have a material effect on the operating results and financial position of the Group and the Company and at this stage it cannot be reliably estimated. The Group and the |
Proceeds from financial assets 555 Interest received |
26 682 |
0 19 |
||||||||||
| Company have formed provisions for tax unaudited years differences amounting to € 2.812 k. and € 363 k. respectively and other | Proceeds from government grants 1.269 |
67 | $\Omega$ | ||||||||||
| provisions amounting to € 134 k. and € 0 k. respectively. 6. At 30/6/2009, the Company owned 191.854 treasury shares, acquired for a total amount of € 917 k At 30/6/2009, the Group |
Dividends received (28.743) Net cash used in investing activities (b) |
1.775 (34.818) |
882 | 779 5.656 |
|||||||||
| owned 2.302.173 treasury shares (shares of the parent company), acquired for a total amount of € 12.866 k | Cash flows from financing activities. | ||||||||||||
| 7. Other comprehensive income for the period, net of taxes, for the Group and the Company are as follows: | GROUP | COMPANY | Proceeds from / Repayment of borrowings Repayment of finance lease liabilities |
18.509 1.137 |
102.513 (6.409) |
[3.344] | 10.265 o |
||||||
| Revaluation of investments assets in fair values | 1/1-30/6/2009 2.048 |
1/1-30/6/2008 1/1-30/6/2009 | 1/1-30/6/2008 | Dividends paid | [1.337] | [2.296] | (29) | [269] | |||||
| Tax income of the other comprehensive income | (413) | (15) | Board of Directors' fees Net cash generated from / [used in] financing activites [c] |
(771) 17.538 |
(610) 93.198 |
(3.373) | o 9.996 |
||||||
| Other comprehensive income after taxes | 1.636 | Net increase / (decrease) in cash & cash equivalents | [2.883] | 21.526 30.843 |
(39) | 4.183 | |||||||
| 8. Group companies established (see note 3 to the financial statements) that have been established and included in the consolidated financial statements of the closing period with the full consolidation method and had not been included in the |
Cash & cash equivalents at the beginning of the period 38.660 Cash $@$ cash equivalents at the end of the period 35.777 |
363 152 4.546 113 |
|||||||||||
| financial statements of the immediately previous period nor in those of the respective period of the previous year, are the following: PRIVATE DIAGNOSTIC LABORATORY EUROMEDICA TRIKALA S.A. on 1/2/2009 (participating interest 14,41%), PRIVATE |
|||||||||||||
| NEUROPSYCHIATRIC CLINIC KASTALIA S.A. on 31/3/2009 (participating interest 15,64%), EUROMEDICA S.A. REAL ESTATE on 16/4/2009 (participating interest 99.94%), EUROMEDICA GULF S.A. HOLDINGS on 16/2/2009 (participating interest 62.95%) and |
YEAR / PERIOD | Total comprehensive income after taxes | Reformed balance (see notes 5 and 13). | ||||||||||
| GENIKI NOSILEFTIKI S.A. GENERAL SERVICES on 23/4/2009 (participating interest 25,03%). | GROUP | Balances as they have been published | COMPANY | GROUP | COMPANY | ||||||||
| Group associated companies that have been established (see note 3 to the interim financial statements) that have been established and included in the consolidated financial statements of the closing period with the equity method and had not been included in the |
1/1-31/12/2008 1/1-30/6/2008 |
[17.375] [14.049] |
457 7.134 |
[17.377] [15.442] |
457 -2 |
||||||||
| financial statements of the immediately previous period nor in those of the respective period of the previous year, are the following: EUROMEDICA COSMETIC PRIVATE POLYIATREIO S.A. on 31/3/2009 (participating interest 22,84%), EUROMEDICA |
|||||||||||||
| WESTERN MACEDONIA-KOZANI S.A. on 24/11/2008 (participating interest 15,62%). | YEAR / PERIOD | Total Equity attributable to parent's shareholders Balances as they have been published |
Reformed balance (see notes 5 and 13) | ||||||||||
| 9. Group companies acquired (see note 3 to the interim financial statements) and included in the consolidated financial statements of the closing period with the full consolidation method and had not been included in the financial statements of the immediately |
GROUP | COMPANY | GROUP | COMPANY | |||||||||
| previous period nor in those of the respective period of the previous year, are the following. NEUROLOGICAL PSYCHIATRIC CLINIC A. PISSALIDIS – A. KARIPIS S.A. on 25/8/2008 (participating interest 31.29%), VOGIATZIS PRIVATE DIAGNOSTIC LABORATORY S.A. |
1/1-31/12/2008 1/1-30/6/2008 |
108.701 114.148 |
99.184 106.377 |
108.719 112.303 |
99.184 98.659 |
||||||||
| on 3/9/2008 [participating interest 30,04%], DIAGNOSTIC CENTER LARISA S.A. on 15/9/2008 [participating interest 26,28%], | |||||||||||||
| PRIVATE DIAGNOSTIC LABORATORY ALEXANDRIO S.A. on 25/9/2008 (participating interest 30,66%), PRIVATE DIAGNOSTIC LABORATORY OF WESTERN THESSALONIKI S.A. on 25/9/2008 (participating interest 26,28%), AXIAL DIAGNOSIS S.A. on |
YEAR / PERIOD | Profit after taxes and minority interests Balances as they have been published |
Reformed balance [see notes 5 and 13] | ||||||||||
| 13/11/2008 (participating interest 62,58%), EUROMEDICA APOKATASTASI S.A. on 6/11/2008 (participating interest 31,29%), D.S. SIOVAS - RADIODIAGNOSTIC CENTER GREVENA on 1/2/2009 (participating interest 30.66%), ASKLEPIO INFIRMARY LARISA S.A. |
1/1-31/12/2008 | GROUP (9.632) |
COMPANY 500 |
GROUP [9.619] |
COMPANY | 500 | |||||||
| on 1/3/2009 (participating interest 37.55%). | 1/1-30/6/2008 | [8.976] | 7.134 | [10.034] | 2 | ||||||||
| The associate company of the Group (see note 3 to the interim financial statements) that was acquired on 30/6/2009 and included in the consolidated financial statements with the equity method and had not been included in the financial statements of the |
14. Investments in fixed assets for the closing period came up to € 30.750 k. for the Group and € 0 k. for the Company. | ||||||||||||
| immediately previous period nor in those of the respective period of the previous year, is CENTRAL MEDICAL SERVICES S.A. | 15. The cumulative amounts of income and expenses from the beginning of the fiscal year and the balances of receivables and payables of the | ||||||||||||
| (participating interest 17,84%). 10. The subsidiary company S.K.D.S. MANAGEMENT ADVISORS S.A. was consolidated in the consolidated financial statements as |
Group and the Company at the end of the closing period, that have emerged from transactions with related parties as dictated by IAS 24, are analyzed as follows (amounts in thousands of Euro): |
||||||||||||
| at 31/12/2008 by the Equity method, while on 30/6/2009 has been fully consolidated, due to undertaking of the business activities management. |
a) Income | GROUP 250 |
COMPANY 194 |
||||||||||
| 11. There are mortgage prenotations on the real estate property of the Group and the Company, amounting to € 91.545 k. and € 24.800 k. respectively, for granted loans and letters of guarentee the amount of which on 30/6/2009 totaled to € 158.511 k and € |
b) Expenses | 956 | |||||||||||
| 75.569. k. respectively | c] Receivables d] Payables |
42 27.882 9.290 710 |
|||||||||||
| 12. The number of employees of the Group and the Company at the end of the current period was 2.701 and 8 people respectively The number of employees of the Group and the Company at the end of the previous period was 2.475 and 14 people respectively. |
e) Transactions and remuneration of management executives and board members | 186 72 |
|||||||||||
| 13. The total equity and the comprehensive income of the comparative financial statements were reformed due to provisions of tax | f) Receivables from management executives and board members o g) Payables to management executives and board members O |
||||||||||||
| unaudited fiscal years and the finalisation of the goodwill. This had as a consequence the following (amounts in thousands of Euro): | 16. E.B.I.T.D.A. is defined as Earnings before Income Taxes Depreciation and Amortization (Amortisation of government grants and loss/gain from | ||||||||||||
| disposal of fixed assets are not included). Athens, August 26 2009 |
|||||||||||||
| The Chairman of the Board | The Managing Director | The Head of the Accounting Department | |||||||||||
| APOSTOLOS D. TERZOPOULOS | PANAGIOTIS N. DOUMANOGLOU | LOUKAS LIAKOS | |||||||||||
| I.D. No Σ 636315/98 | I.D. No Σ 232215/00 | I.D. No T 017003 UCENCE NA COCECE ECONOMIC CUAMPED 20062 A' DECOEF |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.